Non-pharmacological management of a hemodynamically significant patent ductus arteriosus.

The association between the patent ductus arteriosus (PDA) and neonatal morbidity, mortality and poor neurodevelopmental outcome in later childhood has been the focus of intense debate for decades. The lack of evidence supporting therapeutic strategies aimed at achieving PDA closure has led to the widespread adoption of conservative management aimed at mitigating the impact of shunt volume without achieving ductal closure. In this article, we review this management approach, describe the supportive evidence and potential complications associated with this strategy.

• Publication year

  2018

• Venue

  Seminars in Fetal & Neonatal Medicine

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.siny.2018.03.008PMID 29580939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study

  2018cited by this paper
• A conservative treatment of patent ductus arteriosus in very low birth weight infants.

  2017cited by this paper
• Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants

  2017cited by this paper
• Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units

  2017cited by this paper
• Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates

  2017cited by this paper
• Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes

  2017cited by this paper
• Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.

  2016cited by this paper
• Patent Ductus Arteriosus and Brain Volume

  2016cited by this paper
• Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada

  2016cited by this paper
• Reflections of the changes in patent ductus arteriosus management during the last 10 years

  2016cited by this paper
• Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants

  2016cited by this paper
• Diagnosis, Evaluation, and Management of Patent Ductus Arteriosus in Preterm Neonates.

  2015cited by this paper
• Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants.

  2014cited by this paper
• Early growth and neurodevelopmental outcome in very preterm infants: impact of gender

  2014cited by this paper
• Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants.

  2014cited by this paper
• Clinical Pharmacology of Furosemide in Neonates: A Review

  2013cited by this paper
• Optimal Oxygenation of Extremely Low Birth Weight Infants: A Meta-Analysis and Systematic Review of the Oxygen Saturation Target Studies

  2013cited by this paper
• Effect of Positive End-Expiratory Pressure on Ductal Shunting and Systemic Blood Flow in Preterm Infants with Patent Ductus Arteriosus

  2013cited by this paper
• A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus

  2013cited by this paper
• Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus.

  2012cited by this paper
• The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review

  2012cited by this paper
• Learning to live with patency of the ductus arteriosus in preterm infants

  2011cited by this paper
• Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

  2010cited by this paper
• Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?

  2010cited by this paper
• In Vivo Dilatation of the Ductus Arteriosus Induced by Furosemide in the Rat

  2010cited by this paper
• Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants

  2009cited by this paper
• Conservative treatment for patent ductus arteriosus in the preterm

  2007cited by this paper
• Towards rational management of the patent ductus arteriosus: the need for disease staging

  2007cited by this paper
• Patent ductus arteriosus: evidence for and against treatment.

  2007cited by this paper
• Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less

  2006cited by this paper
• Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management

  2005cited by this paper
• Treatment of patent ductus arteriosus.

  2003cited by this paper
• Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.

  2003cited by this paper
• Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.

  2003cited by this paper
• Combining low inspired oxygen and carbon dioxide during mechanical ventilation for the Norwood procedure

  2003cited by this paper
• Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

  2002cited by this paper
• Hemodynamic effects of inspired carbon dioxide after the Norwood procedure.

  2001cited by this paper
• Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.

  2001cited by this paper
• Cardiovascular effects of mechanical ventilation

  1999cited by this paper
• Randomized Trial of Permissive Hypercapnia in Preterm Infants: A Pilot Study. • 962

  1997cited by this paper
• Fetal model of single ventricle physiology: hemodynamic effects of oxygen, nitric oxide, carbon dioxide, and hypoxia in the early postnatal period.

  1996cited by this paper
• Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants.

  1996cited by this paper
• Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.

  1996cited by this paper
• Experimental model of single ventricle. Influence of carbon dioxide on pulmonary vascular dynamics.

  1994cited by this paper
• Review of studies evaluating ductal patency in the premature infant.

  1993cited by this paper
• Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome.

  1992cited by this paper
• Effect of pH and PCO2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension.

  1988cited by this paper
• Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome.

  1983cited by this paper
• Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects.

  1982cited by this paper
• Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.

  1982cited by this paper
• Patent Ductus Arteriosus in Preterm Infants

  1980cited by this paper

• CD71+ erythroid cells as a potential early biomarker for hemodynamic significant patent ductus arteriosus in preterm infants

  2026cites this paper
• Contemporary Management Strategies for Patent Ductus Arteriosus.

  2026cites this paper
• Patent Ductus Arteriosus in Preterm Infants.

  2025cites this paper
• DUCTUS ARTERIOSUS PERSISTENS KOD PREMATURUSA - KONTROVERZE TERAPIJSKOG PRISTUPA I PRIDRUŽENIH KOMORBIDITETA

  2025cites this paper
• Developing a Multivariable Prediction Model to Identify a High-Volume Patent Ductus Arteriosus in Neonates Born Extremely Preterm.

  2025cites this paper
• Caffeine-Associated Reduction in Patent Ductus Arteriosus (PDA) is Mediated in Part by Adenosine Receptor Antagonism.

  2025cites this paper
• Perinatal Factors Associated with Successful Pharmacologic Closure of the Patent Ductus Arteriosus in Premature Infants

  2024cites this paper
• Management of patent ductus arteriosus in preterm infants: Abundant literature, low certainty of evidence for clinicians.

  2024cites this paper
• Who Still Gets Ligated? Reasons for Persistence of Surgical Ligation of the Patent Ductus Arteriosus Following Availability of Transcatheter Device Occlusion for Premature Neonates

  2024cites this paper
• Hemodynamically Significant Patent Ducts Arteriosus: Impact of Ductal Size on Left Output and Aortic Doppler Velocimetry

  2024cites this paper
• Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus

  2024cites this paper
• Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants

  2023cites this paper
• Nutrition with a patent ductus arteriosus: feast, feed, or famine?

  2023cites this paper
• Patent Ductus Arteriosus in Premature Infants: Clinical Trials and Equipoise.

  2023cites this paper
• Invasive management for patent ductus arteriosus in preterm infants

  2023cites this paper
• Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in "22-23" week and "24-26" infants.

  2023cites this paper
• The role of furosemide and fluid management for a hemodynamically significant patent ductus arteriosus in premature infants

  2022influential citation
• Definitive Closure of the Patent Ductus Arteriosus in Preterm Infants and Subsequent Short-Term Respiratory Outcomes

  2022influential citation
• Fluid and electrolyte management in preterm infants with patent ductus arteriosus

  2022cites this paper
• The patent ductus arteriosus management debate: it’s not over yet

  2021cites this paper
• Non-Pharmacological Interventions for Anemia Treatment: Systematic Review

  2021cites this paper
• Respiratory Decompensation in Preterm Infants Following Surgical Ligation or Device Closure of the Patent Ductus Arteriosus

  2020influential citation
• Is high platelet distribution width in the first hours of life can predict hemodynamically significant patent ductus arteriosus in preterm newborns?

  2020cites this paper
• Role of sequential functional echocardiography in predicting clinically apparent patent ductus arteriosus in preterm very low birth weight newborns: An observational study

  2020cites this paper
• Patent ductus arteriosus and cerebral, cardiac, and gut hemodynamics in premature neonates.

  2020cites this paper
• Defining “Haemodynamic Significance” of the Patent Ductus Arteriosus: Do We Have All the Answers?

  2020cites this paper
• Echocardiographic predictors of acute kidney injury in neonates with a patent ductus arteriosus

  2019cites this paper
• Regional tissue oxygenation monitoring in the neonatal intensive care unit: evidence for clinical strategies and future directions

  2019cites this paper
• Patent ductus arteriosus in extremely preterm infants : characteristics, risk factors and treatment decisions

  2019influential citation
• Preterm patent ductus arteriosus: what the research tells us

  2019cites this paper
• Percutaneous closure of the patent ductus arteriosus: opportunities moving forward.

  2019cites this paper
• The definition of a hemodynamically significant ductus arteriosus

  2019cites this paper
• Clinical outcomes after more conservative management of patent ductus arteriosus in preterm infants

  2018cites this paper